The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance

1.

Maron BJ: Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002, 287: 1308-1320. 10.1001/jama.287.10.1308.

PubMed  Google Scholar 

2.

O'Hanlon R, Pennell DJ: Cardiovascular magnetic resonance in the evaluation of hypertrophic and infiltrative cardiomyopathies. Heart Fail Clin. 2009, 5: 369-387. 10.1016/j.hfc.2009.02.003. vi

PubMed  Google Scholar 

3.

Judge DP, Johnson NM: Genetic evaluation of familial cardiomyopathy. J Cardiovasc Transl Res. 2008, 1: 144-154. 10.1007/s12265-008-9025-1.

PubMed  Google Scholar 

4.

Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, Bonne G, Guicheney P, Hainque B, Bouhour JB: Penetrance of familial hypertrophic cardiomyopathy. Genet Couns. 1997, 8: 107-114.

CAS  PubMed  Google Scholar 

5.

Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB: Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006, 113: 1807-1816. 10.1161/CIRCULATIONAHA.106.174287.

PubMed  Google Scholar 

6.

Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM, van Rossum AC: Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol. 2006, 48: 2518-2523. 10.1016/j.jacc.2006.08.036.

PubMed  Google Scholar 

7.

Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED: American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003, 42: 1687-1713. 10.1016/S0735-1097(03)00941-0.

PubMed  Google Scholar 

8.

Towbin JA: Hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2009, 32 (Suppl 2): S23-31.

PubMed  Google Scholar 

9.

Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ: Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000, 36: 2212-2218. 10.1016/S0735-1097(00)01003-2.

CAS  PubMed  Google Scholar 

10.

Spirito P, Seidman CE, McKenna WJ, Maron BJ: The management of hypertrophic cardiomyopathy. N Engl J Med. 1997, 336: 775-785. 10.1056/NEJM199703133361107.

CAS  PubMed  Google Scholar 

11.

Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ: Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008, 29: 270-276.

PubMed  Google Scholar 

12.

Rose AG: Evaluation of pathological criteria for diagnosis of hypertrophic cardiomyopathy. Histopathology. 1984, 8: 395-406. 10.1111/j.1365-2559.1984.tb02352.x.

CAS  PubMed  Google Scholar 

13.

Dawson DK, Maceira AM, Raj VJ, Graham C, Pennell DJ, Kilner PJ: Regional thicknesses and thickening of compacted and trabeculated myocardial layers of the normal left ventricle studied by cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2011, 4: 139-146. 10.1161/CIRCIMAGING.110.960229.

PubMed Central  PubMed  Google Scholar 

14.

Teare D: Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958, 20: 1-8. 10.1136/hrt.20.1.1.

PubMed Central  CAS  PubMed  Google Scholar 

15.

Hughes SE: The pathology of hypertrophic cardiomyopathy. Histopathology. 2004, 44: 412-427. 10.1111/j.1365-2559.2004.01835.x.

CAS  PubMed  Google Scholar 

16.

Davies MJ, McKenna WJ: Hypertrophic cardiomyopathy-pathology and pathogenesis. Histopathology. 1995, 26: 493-500. 10.1111/j.1365-2559.1995.tb00267.x.

CAS  PubMed  Google Scholar 

17.

Klues HG, Maron BJ, Dollar AL, Roberts WC: Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation. 1992, 85: 1651-1660.

CAS  PubMed  Google Scholar 

18.

Maron BJ, Roberts WC: Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation. 1979, 59: 689-706.

CAS  PubMed  Google Scholar 

19.

Davies MJ: The current status of myocardial disarray in hypertrophic cardiomyopathy. Br Heart J. 1984, 51: 361-363. 10.1136/hrt.51.4.361.

PubMed Central  CAS  PubMed  Google Scholar 

20.

Factor SM, Butany J, Sole MJ, Wigle ED, Williams WC, Rojkind M: Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1991, 17: 1343-1351. 10.1016/S0735-1097(10)80145-7.

CAS  PubMed  Google Scholar 

21.

Maron BJ, Wolfson JK, Epstein SE, Roberts WC: Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986, 8: 545-557. 10.1016/S0735-1097(86)80181-4.

CAS  PubMed  Google Scholar 

22.

Takemura G, Takatsu Y, Fujiwara H: Luminal narrowing of coronary capillaries in human hypertrophic hearts: an ultrastructural morphometrical study using endomyocardial biopsy specimens. Heart. 1998, 79: 78-85.

PubMed Central  CAS  PubMed  Google Scholar 

23.

Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich AG, Maron BJ: Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005, 112: 855-861. 10.1161/CIRCULATIONAHA.104.507723.

PubMed  Google Scholar 

24.

Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E: Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009, 54: 220-228. 10.1016/j.jacc.2009.05.006.

PubMed  Google Scholar 

25.

Elliott P, McKenna WJ: Hypertrophic cardiomyopathy. Lancet. 2004, 363: 1881-1891. 10.1016/S0140-6736(04)16358-7.

CAS  PubMed  Google Scholar 

26.

Cannavale A, Ordovas KG, Higgins CB: Magnetic Resonance Imaging of Hypertrophic Cardiomyopathy. J Thorac Imaging. 2010

Google Scholar 

27.

Wigle ED: Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy. Heart. 2001, 86: 709-714. 10.1136/heart.86.6.709.

PubMed Central  CAS  PubMed  Google Scholar 

28.

Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ: Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation. 2011, 124: 40-47. 10.1161/CIRCULATIONAHA.110.985812.

CAS  PubMed  Google Scholar 

29.

Hansen MW, Merchant N: MRI of hypertrophic cardiomyopathy: part I, MRI appearances. AJR Am J Roentgenol. 2007, 189: 1335-1343. 10.2214/AJR.07.2286.

PubMed  Google Scholar 

30.

Olivotto I, Maron MS, Autore C, Lesser JR, Rega L, Casolo G, De Santis M, Quarta G, Nistri S, Cecchi F: Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008, 52: 559-566. 10.1016/j.jacc.2008.04.047.

PubMed  Google Scholar 

31.

Seidman JG, Seidman C: The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001, 104: 557-567. 10.1016/S0092-8674(01)00242-2.

CAS  PubMed  Google Scholar 

32.

Spirito P, Maron BJ, Bonow RO, Epstein SE: Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol. 1987, 60: 123-129. 10.1016/0002-9149(87)90998-2.

CAS  PubMed  Google Scholar 

33.

Shirani J, Pick R, Roberts WC, Maron BJ: Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 2000, 35: 36-44. 10.1016/S0735-1097(99)00492-1.

CAS  PubMed  Google Scholar 

34.

Sperling RT, Parker JA, Manning WJ, Danias PG: Apical hypertrophic cardiomyopathy: clinical, electrocardiographic, scintigraphic, echocardiographic, and magnetic resonance imaging findings of a case. J Cardiovasc Magn Reson. 2002, 4: 291-295. 10.1081/JCMR-120003956.

PubMed  Google Scholar 

35.

Moon JC, Fisher NG, McKenna WJ, Pennell DJ: Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart. 2004, 90: 645-649. 10.1136/hrt.2003.014969.

PubMed Central  CAS  PubMed  Google Scholar 

36.

Suzuki J, Shimamoto R, Nishikawa J, Yamazaki T, Tsuji T, Nakamura F, Shin WS, Nakajima T, Toyo-Oka T, Ohotomo K: Morphological onset and early diagnosis in apical hypertrophic cardiomyopathy: a long term analysis with nuclear magnetic resonance imaging. J Am Coll Cardiol. 1999, 33: 146-151. 10.1016/S0735-1097(98)00527-0.

CAS  PubMed  Google Scholar 

37.

Osman NF, Kerwin WS, McVeigh ER, Prince JL: Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magn Reson Med. 1999, 42: 1048-1060. 10.1002/(SICI)1522-2594(199912)42:6<1048::AID-MRM9>3.0.CO;2-M.

PubMed Central  CAS  PubMed  Google Scholar 

38.

Bergey PD, Axel L: Focal hypertrophic cardiomyopathy simulating a mass: MR tagging for correct diagnosis. AJR Am J Roentgenol. 2000, 174: 242-244.

CAS  PubMed  Google Scholar 

39.

Lever HM, Karam RF, Currie PJ, Healy BP: Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation. 1989, 79: 580-589. 10.1161/01.CIR.79.3.580.

CAS  PubMed  Google Scholar 

40.

Solomon SD, Wolff S, Watkins H, Ridker PM, Come P, McKenna WJ, Seidman CE, Lee RT: Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol. 1993, 22: 498-505. 10.1016/0735-1097(93)90055-6.

CAS  PubMed  Google Scholar 

41.

Ackerman MJ, VanDriest SL, Ommen SR, Will ML, Nishimura RA, Tajik AJ, Gersh BJ: Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J Am Coll Cardiol. 2002, 39: 2042-2048. 10.1016/S0735-1097(02)01900-9.

CAS  PubMed  Google Scholar 

42.

Kokado H, Shimizu M, Yoshio H, Ino H, Okeie K, Emoto Y, Matsuyama T, Yamaguchi M, Yasuda T, Fujino N: Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation. 2000, 102: 663-669.

CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif